Blog

All News In the News News Releases



Supporting ‘breakthrough ideas’ that help patients decide

January 15, 2015
By Margie Coloian

Harlan Krumholz, MD wants to dispel two widely believed myths about healthcare: that more of it is better, and that the costliest is the highest quality. Too often patients are not aware of all the healthcare choices that are available to them and the reasonable range of decisions that could be made.

Read More

You made it happen: Great progress, an enduring promise

January 14, 2015

By Vikas Saini, MD and Shannon Brownlee, MSc

Thanks to all of you, this has been an extraordinary year. Two RightCare regional meetings have been held, the first in Denver, and another in Washington, DC, and there are at least eight more scheduled around the U.S. for 2015. We’ve doubled the membership for the RightCare Alliance; so many clinicians across the country are eager to learn how they can help reshape healthcare to make it more effective and just.

Read More

In Memoriam

Thomas B. Graboys, MD  The Lown Institute family mourns the loss of Thomas B. Graboys, MD, president emeritus of the Institute and former director of the Lown Cardiovascular Center, who died on January 5. Dr. Graboys was a senior physician at the Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School. […]

Read More

Still standing up after sitting in

January 12, 2015

By Margie Coloian

Anybody who followed the controversy over the diabetes drug rosiglitazone (trade name Avandia) knows that Dr. Steve Nissen played a central role in the Food and Drug Administration’s decision to issue a warning about the drug’s cardiovascular risks. He was also involved in blowing the whistle in 2001 in identifying the cardiovascular risk of the pain medication Vioxx. But Nissen’s history of activism began long before.

Read More



A better flu shot for the elderly? High dose flu vaccine as a breakthrough?

By Andy Lazris, MD
December 21, 2014

Should high dose flu shots be used in the elderly? The New York Times said it best, mirroring the chorus of praise in the press after a major study evaluated the efficacy of high dose flu vaccine in the elderly compared to standard dose: “Now a study, published recently in The New England Journal of Medicine, finds that Fluzone High-Dose does indeed prevent influenza in older adults, reducing cases of the flu by 24 percent compared with the standard version.”

Read More